Moleculin Biotech Inc Net Asset Quality Index
Moleculin Biotech Inc net asset quality index. Moleculin Biotech Inc (MBRX) has a Net Asset Quality Index of 67.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $22.13 Million minus total liabilities of $7.12 Million yields net assets of $15.01 Million. A higher index indicates a stronger, lower-leverage balance sheet. See MBRX book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Moleculin Biotech Inc (2015–2025)
Net asset quality index of Moleculin Biotech Inc from 2015 to 2025. This chart shows how Moleculin Biotech Inc's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the index stands at 67.8%, representing net assets of $15.01 Million against total assets of $22.13 Million USD. Check Moleculin Biotech Inc (MBRX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Moleculin Biotech Inc Net Asset Quality Index by Year (2015–2025)
Moleculin Biotech Inc net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for Moleculin Biotech Inc from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MBRX company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.8% | $15.01 Million | $22.13 Million | $7.12 Million | ▲ +32.5 pp |
| 2024 | 35.3% | $5.98 Million | $16.93 Million | $10.95 Million | ▼ -32.9 pp |
| 2023 | 68.2% | $26.07 Million | $38.22 Million | $12.14 Million | ▼ -22.7 pp |
| 2022 | 90.9% | $52.19 Million | $57.42 Million | $5.23 Million | ▼ -3.0 pp |
| 2021 | 93.9% | $78.99 Million | $84.09 Million | $5.10 Million | ▲ +32.6 pp |
| 2020 | 61.3% | $17.89 Million | $29.16 Million | $11.27 Million | ▼ -0.4 pp |
| 2019 | 61.7% | $15.57 Million | $25.23 Million | $9.66 Million | ▼ -11.2 pp |
| 2018 | 72.9% | $14.27 Million | $19.59 Million | $5.31 Million | ▼ -15.0 pp |
| 2017 | 87.9% | $17.12 Million | $19.48 Million | $2.37 Million | ▼ -3.4 pp |
| 2016 | 91.3% | $14.96 Million | $16.39 Million | $1.43 Million | ▲ +2742.3 pp |
| 2015 | -2651.0% | $-744.70K | $28.09K | $772.79K | — |